目的:采用网络药理学的方法分析预测出地榆皂苷Ⅱ(ZiyuglycosideⅡ)治疗鼻咽癌(NPC)的相关作用靶点及通路,并通过实验进行验证。方法:通过Pubchem、Swiss Target Prediction、GeneCards等数据库查询获得地榆皂苷Ⅱ治疗鼻咽癌的相关作用...目的:采用网络药理学的方法分析预测出地榆皂苷Ⅱ(ZiyuglycosideⅡ)治疗鼻咽癌(NPC)的相关作用靶点及通路,并通过实验进行验证。方法:通过Pubchem、Swiss Target Prediction、GeneCards等数据库查询获得地榆皂苷Ⅱ治疗鼻咽癌的相关作用靶点,并运用David数据库对靶点进行基因本体(GO)功能富集分析和京都基因与基因组百科全书(KEGG)通路富集分析,最后构建出"药物—靶点—疾病—通路"关系网络模型图。通过CCK-8细胞毒性实验探究地榆皂苷Ⅱ对鼻咽癌5-8F细胞增殖的影响。通过蛋白质印迹法(Western blotting)对预测出的靶点及其涉及到的信号通路进行验证。结果:网络药理学结果预测显示,地榆皂苷Ⅱ治疗鼻咽癌的潜在靶点有38个,GO功能注释和KEGG通路富集显示其机制可能与调控癌症信号通路(pathway in cancer)、磷脂酰肌醇-3激酶(PI3K)/蛋白激酶B(AKT)信号通路、癌症蛋白聚糖通路(proteoglycans in cancer)、叉头转录因子O亚族(FOXO)信号通路等有关。实验结果显示,地榆皂苷Ⅱ对鼻咽癌5-8F细胞的增殖有明显的抑制作用,地榆皂苷Ⅱ可明显下调AKT蛋白和PI3K蛋白水平(P<0.05)。结论:地榆皂苷Ⅱ可有效抑制鼻咽癌5-8F细胞的增殖,其抗鼻咽癌机制可能与抑制PI3K/AKT信号通路活性有关。展开更多
OBJECTIVE: To confirm the anti-NPC effect of sanguinarine(SA) through a series of wet experiments.METHODS: NPC cell viability was determined by proliferation experiment. Cell clone formation experiment, cell scratch t...OBJECTIVE: To confirm the anti-NPC effect of sanguinarine(SA) through a series of wet experiments.METHODS: NPC cell viability was determined by proliferation experiment. Cell clone formation experiment, cell scratch test, transwell migration and invasion experiment and flow cytometry-based cell apoptosis assay were further performed. In addition, Western blotting was performed to investigate the cell signaling pathway. All the relevant experimental data were statistically processed using SPSS 16.0 software.RESULTS: The results showed that sanguinarine represented a time and dose dependent inhibition effects on NPC cell proliferation including the low differentiated CNE2 cells and high metastatic 5-8F cells, along with the cell cloning ability reduction. In addition, sanguinarine has a certain inhibitory effect on the invasion and migration of NPC cells. Mechanistically, sanguinarine displayed the anti-NPC effects mainly involved into the suppression of m TOR signaling and cell apoptosis, which is closely associated with the tumor growth and metastatic malignancy. CONCLUSIONS: Collectively, we discover that sanguinarine is a new high-efficiency anti-NPC monomer of Chinese medicine, with a value for the follow-up preclinical research.展开更多
文摘目的:采用网络药理学的方法分析预测出地榆皂苷Ⅱ(ZiyuglycosideⅡ)治疗鼻咽癌(NPC)的相关作用靶点及通路,并通过实验进行验证。方法:通过Pubchem、Swiss Target Prediction、GeneCards等数据库查询获得地榆皂苷Ⅱ治疗鼻咽癌的相关作用靶点,并运用David数据库对靶点进行基因本体(GO)功能富集分析和京都基因与基因组百科全书(KEGG)通路富集分析,最后构建出"药物—靶点—疾病—通路"关系网络模型图。通过CCK-8细胞毒性实验探究地榆皂苷Ⅱ对鼻咽癌5-8F细胞增殖的影响。通过蛋白质印迹法(Western blotting)对预测出的靶点及其涉及到的信号通路进行验证。结果:网络药理学结果预测显示,地榆皂苷Ⅱ治疗鼻咽癌的潜在靶点有38个,GO功能注释和KEGG通路富集显示其机制可能与调控癌症信号通路(pathway in cancer)、磷脂酰肌醇-3激酶(PI3K)/蛋白激酶B(AKT)信号通路、癌症蛋白聚糖通路(proteoglycans in cancer)、叉头转录因子O亚族(FOXO)信号通路等有关。实验结果显示,地榆皂苷Ⅱ对鼻咽癌5-8F细胞的增殖有明显的抑制作用,地榆皂苷Ⅱ可明显下调AKT蛋白和PI3K蛋白水平(P<0.05)。结论:地榆皂苷Ⅱ可有效抑制鼻咽癌5-8F细胞的增殖,其抗鼻咽癌机制可能与抑制PI3K/AKT信号通路活性有关。
文摘目的:运用网络药理学的方法预测甘草查尔酮A(LCA)抗鼻咽癌的潜在作用靶点及作用机制。方法:通过PubChem平台获得LCA的3D结构,并用Swiss Target Prediction数据库筛选出LCA靶点以及Uniprot数据库进行靶点蛋白和基因信息校正,得到相应的基因名称数据库。通过人类基因组注释数据库(genecards)搜集与鼻咽癌相关的靶基因,与LCA所对应的靶点作交集,获得共同的潜在靶点。运用STRING数据库构建蛋白质间的相互作用,并进行基因本体(gene ontology,GO)和京都基因与基因组百科全书(kyoto encyclopedia of genes and genomes,KEGG)功能富集分析,以鉴定分子生物学过程和信号通路。最后,构建“药物-靶点-疾病-通路”网络模型。结果:筛选出鼻咽癌与LCA的共同作用靶点共41个。GO功能富集分析显示生物学过程和功能主要集中在蛋白质磷酸化、凋亡过程的负反馈调节、细胞质以及蛋白质黏合等方面。KEGG功能富集表明富集较多的通路主要有癌症相关信号通路、酒精通路、MAPK信号通路以及癌症微小核糖核酸表达等。“药物-靶点-疾病-通路”网络图显示关键基因主要有MAPK14、MAPK10、MAPK1、RAF1等。结论:运用网络药理学方法,预测了LCA治疗鼻咽癌的潜在药物靶点,并初步阐明了其潜在药理机制,为后续研究提供一定的理论依据。
基金Supported by Project for Department of Science and Technology of Guangxi Zhuang Autonomous Region,China,Screening,Product Development and Mechanism Research of Anti-Nasopharyngeal Cancer Chinese Medicine Monomers (AB19110052)Natural Science Foundation of Guangxi,China,Epstein-Barr Virus Infection and UpRegulation Mechanism of Invasion and Migration-Related Proteins S100A8 and S100A9 in Nasopharyngeal Carcinoma Cells (2015GXNSFAA139215)National Natural Science Foundation of China,Quantification,Validation,Functional Analysis and Construction of Regulatory Pathway of i TRAQ Serum Protein Molecular Markers in Nasopharyngeal Carcinoma (81260405)。
文摘OBJECTIVE: To confirm the anti-NPC effect of sanguinarine(SA) through a series of wet experiments.METHODS: NPC cell viability was determined by proliferation experiment. Cell clone formation experiment, cell scratch test, transwell migration and invasion experiment and flow cytometry-based cell apoptosis assay were further performed. In addition, Western blotting was performed to investigate the cell signaling pathway. All the relevant experimental data were statistically processed using SPSS 16.0 software.RESULTS: The results showed that sanguinarine represented a time and dose dependent inhibition effects on NPC cell proliferation including the low differentiated CNE2 cells and high metastatic 5-8F cells, along with the cell cloning ability reduction. In addition, sanguinarine has a certain inhibitory effect on the invasion and migration of NPC cells. Mechanistically, sanguinarine displayed the anti-NPC effects mainly involved into the suppression of m TOR signaling and cell apoptosis, which is closely associated with the tumor growth and metastatic malignancy. CONCLUSIONS: Collectively, we discover that sanguinarine is a new high-efficiency anti-NPC monomer of Chinese medicine, with a value for the follow-up preclinical research.